Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma

Clinical trial NCT03605719 · COMPLETED

Trial details

NCT number: NCT03605719
Sponsor: Emory University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Plasma Cell Myeloma

Start date: 2018-10-24
Primary completion: 2022-10-10
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.